Richman, Susan D., Adams, Richard Alexander ORCID: https://orcid.org/0000-0003-3915-7243, Quirke, Phil, Butler, Rachel, Hemmings, Gemma, Chambers, Phil, Roberts, Helen, James, Michelle D., Wozniak, Sue, Bathia, Riya, Pugh, Cheryl, Maughan, Timothy Stanley and Jasani, Bharat 2015. Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial. Journal of Clinical Pathology 69 (1) , pp. 35-41. 10.1136/jclinpath-2015-203097 |
Smith, Chris, Fisher, D., Claes, B., Maughan, T. S., Idziaszczyk, Shelley, Peuteman, G., Harris, Rebecca, James, Michelle D., Meade, A., Jasani, Bharat, Adams, Richard A. ORCID: https://orcid.org/0000-0003-3915-7243, Kenny, S., Kaplan, R., Lambrechts, D. and Cheadle, Jeremy P. ORCID: https://orcid.org/0000-0001-9453-8458 2013. Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab. Clinical Cancer Research 19 (15) , pp. 4104-4113. 10.1158/1078-0432.CCR-12-2581 |
Maughan, Timothyn S., Adams, Richard A. ORCID: https://orcid.org/0000-0003-3915-7243, Smith, Chris, Meade, Angela M., Seymour, Matthew T., Wilson, Richard H., Idziaszczyk, Shelley A., Harris, Rebecca, Fisher, David, Kenny, Sarah L., Kay, Edward, Mitchell, Jenna K., Madi, Ayman, Jasani, Bharat, James, Michelle D., Bridgewater, John, Kennedy, M. John, Claes, Bart, Lambrechts, Diether, Kaplan, Richard and Cheadle, Jeremy P. ORCID: https://orcid.org/0000-0001-9453-8458 2011. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. The Lancet 377 (9783) , pp. 2103-2114. 10.1016/S0140-6736(11)60613-2 |